ZimVie Inc. revised earnings guidance for the full Year Ending December 31, 2023. For the year, the company now expects net Sales to be in the range of $860 million to $870 million against prior guidance of $850 million to $870 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.82 USD | +0.13% | +0.96% | -10.87% |
Apr. 01 | H.I.G. Capital, LLC completed the acquisition of Zimmer Biomet Spine, Inc. from ZimVie Inc.. | CI |
Mar. 18 | ZimVie Inc.(NasdaqGS:ZIMV) added to S&P Healthcare Equipment Select Industry Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.87% | 431M | |
+73.17% | 12.38B | |
-15.87% | 8.2B | |
+17.74% | 7.3B | |
+10.58% | 5.32B | |
+33.33% | 4.78B | |
-18.88% | 4.16B | |
-35.55% | 2.43B | |
+1.49% | 2.05B | |
+9.66% | 1.98B |
- Stock Market
- Equities
- ZIMV Stock
- News ZimVie Inc.
- Zimvie Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023